Abstract

The protozoan parasite Trypanosoma brucei is the causative agent of human African sleeping sickness and related animal diseases, and it has over 170 predicted protein kinases. Protein phosphorylation is a key regulatory mechanism for cellular function that, thus far, has been studied in T.brucei principally through putative kinase mRNA knockdown and observation of the resulting phenotype. However, despite the relatively large kinome of this organism and the demonstrated essentiality of several T. brucei kinases, very few specific phosphorylation sites have been determined in this organism. Using a gel-free, phosphopeptide enrichment-based proteomics approach we performed the first large scale phosphorylation site analyses for T.brucei. Serine, threonine, and tyrosine phosphorylation sites were determined for a cytosolic protein fraction of the bloodstream form of the parasite, resulting in the identification of 491 phosphoproteins based on the identification of 852 unique phosphopeptides and 1204 phosphorylation sites. The phosphoproteins detected in this study are predicted from their genome annotations to participate in a wide variety of biological processes, including signal transduction, processing of DNA and RNA, protein synthesis, and degradation and to a minor extent in metabolic pathways. The analysis of phosphopeptides and phosphorylation sites was facilitated by in-house developed software, and this automated approach was validated by manual annotation of spectra of the kinase subset of proteins. Analysis of the cytosolic bloodstream form T. brucei kinome revealed the presence of 44 phosphorylated protein kinases in our data set that could be classified into the major eukaryotic protein kinase groups by applying a multilevel hidden Markov model library of the kinase catalytic domain. Identification of the kinase phosphorylation sites showed conserved phosphorylation sequence motifs in several kinase activation segments, supporting the view that phosphorylation-based signaling is a general and fundamental regulatory process that extends to this highly divergent lower eukaryote.

Highlights

  • The protozoan parasite Trypanosoma brucei is the causative agent of human African sleeping sickness and related animal diseases, and it has over 170 predicted protein kinases

  • Characterization of the T. brucei Kinome—Using a highly sensitive and specific multilevel hidden Markov model (HMM) we identified 170 ePKs and 12 atypical protein kinases (aPKs)

  • No protein kinases were found to contain more than one kinase catalytic domain

Read more

Summary

EXPERIMENTAL PROCEDURES

Cell Preparation and Lysis—Bloodstream form T. brucei glycosylphosphatidylinositol-specific phospholipase C-null mutant strain RUMP 528 cells (21) were isolated from infected rats and purified over DEAE-cellulose (22). All peptide hits from forward and reverse databases corresponding to proteins in the non-redundant set and meeting the quality criteria described above were ranked by Mascot score. (iii) At least three singly charged peptide fragment ions that have lost phosphoric acid (Ϫ98 Da) must be present Those peptides with MS/MS spectra that met these criteria were taken to the second level of phosphorylation site annotation. Regions showing similarity were parsed, and sites were recorded where known phosphorylation sites in the phospho.ELM database aligned with serine, threonine, or tyrosine residues Storage of these data in a relational database facilitated subsequent analysis of the prevalence of known kinase substrate motifs and an evaluation of the efficacy of substrate site prediction programs. T. brucei Phosphoprotein Categories—Functional assignment of the phosphoproteins was performed manually from primary scientific publications because the majority of the phosphoproteins detected in this study have not been mapped to Gene Ontology categories

RESULTS
Kinome as percentage
Mascot searches
Manually annotated phosphorylation sites
TABLE IV Phosphorylation site distributions
Phosphoserine Phosphothreonine Phosphotyrosine
DISCUSSION

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.